MedTrace Logo

Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers

NCT02596711 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2020-03-10

Study results available
· View outcomes & findings →

Summary

The goal of this research study is to learn how 3 different kinds of counseling treatments may help individuals to quit smoking.

Conditions

  • Tobacco Use Cessation
  • Cancer Prevention

Interventions

DRUG

Nicotine Patch

Participants receive 4 weeks of 21 mg, 4 weeks of 14 mg, and 4 weeks of 7 mg patches.

BEHAVIORAL

Questionnaires

Questionnaires regarding tobacco and alcohol use, culture, religion, and sense of control completed at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.

OTHER

Carbon Monoxide (CO) Test

Carbon monoxide (CO) test given at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.

BEHAVIORAL

Health Education and Handouts

Participants receive general health education and handouts.

BEHAVIORAL

Culturally Tailored Reading Materials

Participants given reading materials that highlight how aspects of their culture relate to health, smoking and quitting.

BEHAVIORAL

Counseling Sessions

Participants attend 3 counseling sessions during the study.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Marcel A. de Dios, PHD · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-02
Primary Completion
2017-08-22
Completion
2017-08-22
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02596711 on ClinicalTrials.gov